Skip to main content

Headlines

Lilly's EloraTZP Delivers Weight Loss Results In Phase 2b Trial
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
posted:
by: CNBC Business
#channels:: #All, #News, #Business, #CNBCBusiness, #CNBC, #Stocks, #Markets
Lilly's EBGLYSS Shows Rapid Skin Clearance And Symptom Relief In Phase 3b Study
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Lilly's Retatrutide Drives Significant Weight Loss And A1C Improvement In Phase 3 Diabetes Study
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Lilly's Retatrutide Delivered Significant Weight Loss, A1C Reduction In Phase 3 Trial
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Eli Lilly Might Be the Next Stock I Buy
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Opinion: Eli Lilly Stock Is a No-Brainer Pick to Buy on the Dip
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Bristol Myers Squibb vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Eli Lilly Stock Barely Moved Following Viking Therapeutics' Impressive Clinical Results. Here's Why.
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Lilly: Zepbound Shows Greater Weight Loss Than Wegovy HD In New Analysis
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Lilly's Zepbound Shows Greater Weight Loss Than Wegovy HD In New Analysis
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Lilly's Foundayo Tops Oral Semaglutide In New Diabetes Analysis
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Lilly's Foundayo Outperforms Oral Semaglutide In New Diabetes Analysis
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Could This Mid-Cap GLP-1 Stock Be a Better Buy Than Eli Lilly?
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
posted:
by: Nasdaq Technology
#channels:: #All, #Business, #Nasdaq, #Technology, #NasdaqTechnology, #Stocks